Outcomes of Trimodality Approach in the Management of T2N0M0 Bladder Cancer

Uysal, Bora; Beyzadeoğlu, Murat; Demiral, Selçuk; Gamsiz, Hakan; Dincoglan, Ferrat; Sager, Omer; Akın, Mustafa; Babayiğit, Mustafa Alparslan

doi:10.5301/tj.5000294

Tumori

2015

DOI: 10.5301/tj.5000294

|View full text |Cite

Outcomes of Trimodality Approach in the Management of T2N0M0 Bladder Cancer

Bora Uysal

Murat Beyzadeoğlu

Selçuk Demiral

et al.

Abstract: Bladder preserving approach is an alternative definitive therapy solution to radical cystectomy in the treatment of muscle-invasive bladder cancer with less morbidity, preserved natural bladder, and high quality of life.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 31 publications

(35 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Outcomes of Trimodality Approach in the Management of T2N0M0 Bladder Cancer

Abstract: Bladder preserving approach is an alternative definitive therapy solution to radical cystectomy in the treatment of muscle-invasive bladder cancer with less morbidity, preserved natural bladder, and high quality of life.

Cited by 1 publication

References 31 publications

A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer

A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer

Contact Info

Product

Resources

About